» Authors » E Karnieli

E Karnieli

Explore the profile of E Karnieli including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 53
Citations 719
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Armoni M, Harel C, Karnieli E
Horm Metab Res . 2014 Nov; 47(2):89-96. PMID: 25409419
Being a key-factor in glucose homeostasis, PPARγ transcriptional activity (TA) is of high importance. However, its mediation by ligands and post-translational modifications in insulin target tissues are unclear. We investigated...
2.
Ramdas M, Harel C, Armoni M, Karnieli E
Horm Metab Res . 2014 Aug; 47(4):265-72. PMID: 25153686
AHNAK is a 700 KD phosphoprotein primarily involved in calcium signaling in various cell types and regulating cytoskeletal organization and cell membrane architecture. AHNAK expression has also been associated with...
3.
Armoni M, Harel C, Ramdas M, Karnieli E
Horm Metab Res . 2014 Feb; 46(7):477-83. PMID: 24500986
Impaired GLUT4 function/expression in insulin target tissues is well-documented in diabetes and obesity. Cytochrome P450 isoform 2E1 (CYP2E1) induces oxidative stress, leading to impaired insulin action. CYP2E1 knockout mice are...
4.
Khunti K, Caputo S, Damci T, Dzida G, Ji Q, Kaiser M, et al.
Diabetes Obes Metab . 2012 Jul; 14(12):1129-36. PMID: 22830956
Aims: Evaluate the safety and efficacy of once-daily insulin detemir initiated in routine clinical practice in patients with type 2 diabetes mellitus inadequately controlled with oral hypoglycaemic agents (OHAs). Methods:...
5.
Bohdjalian A, Ludvik B, Guerci B, Bresler L, Renard E, Nocca D, et al.
Surg Endosc . 2008 Dec; 23(9):1955-60. PMID: 19067068
Background: The TANTALUS system (MetaCure Ltd.) is a minimally invasive implantable gastric stimulation modality that does not exhibit malabsorptive or restrictive characteristics. The device applies gastric contractility modulation (GCM) signals...
6.
Bloomgarden Z, Inzucchi S, Karnieli E, Le Roith D
Diabetologia . 2008 May; 51(7):1111-4. PMID: 18449525
The proposed use of a more precise standard for glycated (A(1c)) and non-glycated haemoglobin would lead to an A(1c) value, when expressed as a percentage, that is lower than that...
7.
Fodor A, Harel C, Fodor L, Armoni M, Salmon P, Trono D, et al.
Diabetologia . 2006 Nov; 50(1):121-30. PMID: 17131142
Aims/hypothesis: We examined a clinical model of ex vivo transdifferentiation of primary adult hepatocytes to insulin-secreting cells for the treatment of type 1 diabetes. Materials And Methods: Isolated rat hepatocytes...
8.
Burvin R, LeRoith D, Harel H, Zloczower M, Marbach M, Karnieli E
Growth Horm IGF Res . 2000 Sep; 8(3):205-10. PMID: 10984308
The in vivo effects of the insulin-like growth factor-II (IGF-II) on glucose metabolism is not yet well defined. To assess the acute effect of IGF-II administration on whole body glucose...
9.
Globerman H, Zauberman Y, Makarov T, Beamer B, Yen C, Shuldiner A, et al.
Clin Endocrinol (Oxf) . 2000 Apr; 52(4):479-85. PMID: 10762291
Objectives: To test the hypothesis that the triad of hyperandrogenism, insulin resistance and acanthosis nigricans (HAIRAN syndrome) in the presence of obesity, also known as type C insulin resistance, is...
10.
Goldwaser I, Li J, Gershonov E, Armoni M, Karnieli E, Fridkin M, et al.
J Biol Chem . 1999 Sep; 274(37):26617-24. PMID: 10473627
We report that the vanadium ligand L-Glu(gamma)HXM potentiates the capacity of free vanadium ions to activate glucose uptake and glucose metabolism in rat adipocytes in vitro (by 4-5-fold) and to...